Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-002716
Filing Date
2025-01-27
Accepted
2025-01-27 19:22:57
Documents
1
Period of Report
2025-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738023770.html 4  
1 FORM 4 wk-form4_1738023770.xml 4 3464
  Complete submission text file 0001628280-25-002716.txt   5221
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3621 SOUTH STATE ST 695 KMS PL ANN ARBOR MI 48108
Business Address
OLUKOTUN ADEOYE Y (Reporting) CIK: 0001242615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 25560589